Aleniglipron

Aleniglipron (GSBR-1290) is an oral, small-molecule GLP-1 receptor agonist that engages deep orthosteric binding sites. It has demonstrated efficacy in preclinical research for reducing body weight and enhancing insulin sensitivity, supporting its investigation in metabolic disease models including obesity and type 2 diabetes.

Product Specifications

CAS Number

2685823-26-9

Product Name Alternative

GSBR1290, GSBR-1290

Field of Research

Pharmacology & Drug Discovery

Purity

99.79% (May vary between batches)

Solubility

10% DMSO+90% Corn Oil:3.3 mg/mL (3.6 mM) ; DMSO:80 mg/mL (87.34 mM)

Smiles

C[C@@H]1[C@] (C1) (N2C=3C (C=C2C (=O) N4[C@@H] (C) C5=C (N (N=C5CC4) C6=CC (C) =C (F) C (C) =C6) N7C (=O) N (C=C7) C8=CC (NC) =C (P (CC) (CC) =O) C=C8) =CC (=CC3) C9CCOCC9) C%10=NOC (=O) N%10